title: Chronic total occlusion successfully treated with a bioresorbable everolimus-eluting vascular scaffold.
abstract: Fully bioresorbable vascular scaffolds (BVS) are a new approach to the percutaneous treatment of coronary artery disease. The BVS have not yet been fully tested in complex lesions, including chronic total occlusion (CTO). We report a CTO case successfully treated with a second-generation bioabsorbable drug-eluting scaffold.
authors: Cardiovascular Biomedical Research Unit, Royal Brompton Hospital and Harefield Trust, London, United Kingdom.
authors: Juan Carlos
authors: JC
authors: Rama-Merchan
authors: Cardiovascular Biomedical Research Unit, Royal Brompton Hospital and Harefield Trust, London, United Kingdom.
authors: Alessio
authors: A
authors: Mattesini
authors: Cardiovascular Biomedical Research Unit, Royal Brompton Hospital and Harefield Trust, London, United Kingdom.
authors: Gianni
authors: G
authors: Dall'Ara
authors: Cardiovascular Biomedical Research Unit, Royal Brompton Hospital and Harefield Trust, London, United Kingdom.
authors: Carlo Di
authors: CD
authors: Mario
keywords: bioresorbable vascular scaffold; chronic total occlusion